苦参对AS小鼠肠道菌群结构的影响
Effect of Sophora flavescens on Intestinal Flora Structure of AS Mice
摘要: 目的:通过16S rRNA高通量测序技术研究苦参对AS小鼠肠道菌群结构的影响。方法:ApoE-/-小鼠喂养高脂饲料10周建造动脉粥样硬化模型,同时分别设ApoE-/-小鼠和C57小鼠给予普通饲料喂养作为对照组,另设ApoE-/-小鼠预先给予苦参水溶液灌胃作为预处理组。10周后将造模小鼠随机分为模型组、阳性对照组及苦参高、中、低剂量组,与其余三组一起分别进行给药。给药结束后进行样本采集及肠道菌群测序。结果:各组小鼠肠道菌群结构存在显著差异。与对照组相比,模型组小鼠Lawsonibacter、肠鼠杆菌(Muribaculum)丰度降低,邓氏菌属(Duncaniella)丰度升高;与模型组相比,阳性对照组普雷沃氏菌属(Prevotella)、肠鼠杆菌(Muribaculum)丰度降低;与模型组相比,苦参给药组小鼠Lawsonibacter、泪滴形孢子属(Lacrimispora)、回肠杆菌属(Ileibacterium)丰度升高,邓氏菌属(Duncaniella)、普雷沃氏菌属(Prevotella)丰度降低。模型组小鼠氯代环己烷和氯苯降解途径(Chlorocyclohexane and chlorobenzene degradation)显著上升,苦参给药后丙酮酸代谢途径(Pyruvate metabolism)、柠檬烯和蒎烯降解途径(Limonene and pinene degradation)以及糖酵解/糖异生途径(Glycolysis/Gluconeogenesis)下降,果糖和甘露糖代谢(Fructose and mannose metabolism)通路显著上升。结论:苦参改变了动脉粥样硬化小鼠肠道菌群结构,主要的菌属有Prevotella、Lacrimispora等,并且苦参可能作用的通路有糖酵解/糖异生代谢途径及果糖和甘露糖代谢途径等。
Abstract: Objective: The effect of Sophora flavescens on intestinal microflora of AS mice was studied by 16S rRNA high-throughput sequencing technique. Method: ApoE-/- mice were fed with high-fat diet for 10 weeks to establish atherosclerotic model. At the same time, ApoE-/- mice and C57 mice were fed with normal diet as control group, and ApoE-/- mice were given Sophora flavescens solution as pre-treatment group. ApoE-/- mice were fed with high-fat diet for 10 weeks to establish atherosclerotic model. At the same time, ApoE-/- mice and C57 mice were fed with normal diet as control group, and ApoE-/- mice were given Sophora flavescens solution as pretreatment group. After administration, samples were collected and intestinal floras were sequenced. Results: There were significant dif-ferences in the structure of intestinal flora in each group. Compared with the control group, the abundance of Lawsonibacter and Muribaculum decreased and the abundance of Duncaniella in-creased in the model group. Compared with the model group, the abundance of Prevotella and Mu-ribaculum in the positive control group decreased. Compared with the model group, the abundance of Lawsonibacter, Lacrimispora and Ileibacterium in Sophora flavescens group increased, while that of Duncaniella and Prevotella decreased. Chlorocyclohexane and chlorobenzene degradation path-way increased significantly in model group. After administration of Sophora flavescens, pyruvate metabolism pathway, limonene and pinene degradation pathway and glycolysis/gluconeogenesis pathway decreased, while fructose and mannose metabolism pathway increased significantly. Con-clusion: Sophora flavescens can change the structure of intestinal flora in atherosclerotic mice, and the main bacteria are Prevotella, Lacrimispora and so on. The possible pathways of Sophora fla-vescens are glycolysis/gluconeogenesis and fructose and mannose metabolism.
文章引用:谢珂, 杜京晏, 陈海宁, 马晶鑫, 全德森, 田维毅, 蔡琨. 苦参对AS小鼠肠道菌群结构的影响[J]. 临床医学进展, 2022, 12(11): 10646-10655. https://doi.org/10.12677/ACM.2022.12111533

参考文献

[1] 安冬青, 吴宗贵. 动脉粥样硬化中西医结合诊疗专家共识[J]. 中国全科医学, 2017, 20(5): 507-511.
[2] 董宇, 胡元会, 何健, 等. 脂质组学在心脑血管疾病研究中的应用及对中医药研究的启示[J]. 世界科学技术-中医药现代化, 2022, 24(6): 2487-2494.
[3] 刘君雯. 运动对动脉粥样硬化的影响研究[J]. 现代预防医学, 2013, 40(1): 88-90.
[4] Fattorusso, A., Di Genova, L., Dell’Isola, G.B., et al. (2019) Autism Spectrum Disorders and the Gut Microbiota. Nutrients, 11, Article No. 521. [Google Scholar] [CrossRef] [PubMed]
[5] Fu, J., Bonder, M.J., Cenit, M.C., et al. (2015) The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids. Circulation Research, 117, 817-824. [Google Scholar] [CrossRef
[6] Clarke, G., Stilling, R.M., Kennedy, P.J., et al. (2014) Minireview: Gut Microbiota: The Neglected Endocrine Organ. Molecular Endocrinology, 28, 1221-1238. [Google Scholar] [CrossRef] [PubMed]
[7] Verhaar, B., Prodan, A., Nieuwdorp, M., et al. (2020) Gut Microbiota in Hyperten-sion and Atherosclerosis: A Review. Nutrients, 12, Article No. 2982. [Google Scholar] [CrossRef] [PubMed]
[8] Ulleryd, M.A., Prahl, U., Börsbo, J., et al. (2017) The Association between Autonomic Dysfunction, Inflammation and Atherosclerosis in Men under Investigation for Carotid Plaques. PLOS ONE, 12, e174974. [Google Scholar] [CrossRef] [PubMed]
[9] 吴圣贤, 何芳, 武荣荣. 以“脉生痰核”理论指导动脉粥样硬化研究[J]. 中医杂志, 2017, 58(3): 262-264.
[10] 冯君, 刘建和, 冉俊宁, 等. 从痰、瘀、虚探讨动脉粥样硬化的中西医病机[J]. 陕西中医, 2020, 41(2): 217-219.
[11] 高宇. 基于肠道菌群探讨生姜泻心汤预防伊立替康迟发性腹泻的机制研究[D]: [博士学位论文]. 北京: 北京中医药大学, 2021.
[12] Cao, Y.G., Jing, S., Li, L., et al. (2010) Antiarrhythmic Effects and Ionic Mechanisms of Oxymatrine from Sophora flavescens. Phytotherapy Research, 24, 1844-1849. [Google Scholar] [CrossRef] [PubMed]
[13] 陈海宁, 蔡琨, 郭金洲, 等. 苦参胶囊对高脂饮食诱导的ApoE~(-/-)小鼠动脉粥样硬化的干预效果研究[J]. 贵州中医药大学学报, 2021, 43(3): 19-23.
[14] Liu, Y.X., Qin, Y., Chen, T., et al. (2021) A Practical Guide to Amplicon and Metagenomic Analysis of Micro-biome Data. Protein Cell, 12, 315-330. [Google Scholar] [CrossRef] [PubMed]
[15] 於李龙, 陈文华, 秦路平, 等. 中药与肠道菌群相互作用的研究进展[J]. 浙江中西医结合杂志, 2022, 32(9): 881-884.
[16] Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., et al. (2006) An Obesity-Associated Gut Microbiome with Increased Capacity for Energy Harvest. Nature, 444, 1027-1031. [Google Scholar] [CrossRef] [PubMed]
[17] Stojanov, S., Berlec, A. and Štrukelj, B. (2020) The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel Disease. Microorganisms, 8, Article No. 1715. [Google Scholar] [CrossRef] [PubMed]
[18] Koliada, A., Syzenko, G., Moseiko, V., et al. (2017) Association between Body Mass Index and Firmicutes/Bacteroidetes Ratio in an Adult Ukrainian Population. BMC Microbiology, 17, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
[19] Do, M.H., Lee, E., Oh, M.J., et al. (2018) High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change. Nutrients, 10, Article No. 761. [Google Scholar] [CrossRef] [PubMed]
[20] Larsen, J.M. (2017) The Immune Response to Prevotella Bacteria in Chronic Inflam-matory Disease. Immunology, 151, 363-374. [Google Scholar] [CrossRef] [PubMed]
[21] Valdes, A.M., Walter, J., Segal, E., et al. (2018) Role of the Gut Microbiota in Nutrition and Health. BMJ, 361, k2179. [Google Scholar] [CrossRef] [PubMed]
[22] Hu, J., Lin, S., Zheng, B., et al. (2018) Short-Chain Fatty Acids in Control of Energy Metabolism. Critical Reviews in Food Science and Nutrition, 58, 1243-1249. [Google Scholar] [CrossRef] [PubMed]
[23] Sakamoto, M., Iino, T., Yuki, M., et al. (2018) Lawsonibacter asac-charolyticus gen. nov., sp. nov., a Butyrate-Producing Bacterium Isolated from Human Faeces. International Journal of Systematic and Evolutionary Microbiology, 68, 2074- 2081. [Google Scholar] [CrossRef] [PubMed]
[24] 毛梦琳, 林萍, 熊林林, 等. 参苓白术散和理中汤对AAD动物模型肠道产丁酸菌群多样性变化的影响[J]. 中国实验方剂学杂志, 2021, 27(22): 23-30.
[25] den Hartigh, L.J., Gao, Z., Goodspeed, L., et al. (2018) Obese Mice Losing Weight Due to trans-10, cis-12 Conjugated Linoleic Acid Sup-plementation or Food Restriction Harbor Distinct Gut Microbiota. The Journal of Nutrition, 148, 562-572. [Google Scholar] [CrossRef] [PubMed]
[26] Cox, L.M., Sohn, J., Tyrrell, K.L., et al. (2017) Description of Two Novel Members of the Family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the Murine Intestine, and Emendation to the Description of Faecalibaculum rodentium. International Journal of Systematic and Evolution-ary Microbiology, 67, 1247-1254. [Google Scholar] [CrossRef] [PubMed]
[27] 沈利叶, 黄俊杰, 徐剑钦, 等. 基于肠道菌群探讨雄性WHBE兔与日本大耳白兔胆固醇代谢的差异性[J]. 中国实验动物学报, 2022, 30(1): 31-39.
[28] O’Neill, L.A., Kishton, R.J. and Rathmell, J. (2016) A Guide to Immunometabolism for Immunologists. Nature Reviews Immunology, 16, 553-565. [Google Scholar] [CrossRef] [PubMed]
[29] Sarrazy, V., Viaud, M., Westerterp, M., et al. (2016) Disruption of Glut1 in Hemato-poietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice. Circulation Re-search, 118, 1062-1077. [Google Scholar] [CrossRef
[30] Matsui, R., Xu, S., Maitland, K.A., et al. (2006) Glucose-6-Phosphate Dehydrogenase Deficiency Decreases Vascular Superoxide and Atherosclerotic Lesions in Apolipoprotein E(-/-) Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 910-916. [Google Scholar] [CrossRef
[31] Tappy, L., Lê, K.A., Tran, C., et al. (2010) Fructose and Metabolic Diseases: New Findings, New Questions. Nutrition, 26, 1044-1049. [Google Scholar] [CrossRef] [PubMed]